Free Trial
NASDAQ:RKDA

Arcadia Biosciences Q4 2025 Earnings Report

Arcadia Biosciences logo
$1.15 -0.05 (-4.17%)
As of 04:00 PM Eastern

Arcadia Biosciences EPS Results

Actual EPS
-$0.98
Consensus EPS
-$0.66
Beat/Miss
Missed by -$0.32
One Year Ago EPS
N/A

Arcadia Biosciences Revenue Results

Actual Revenue
$0.90 million
Expected Revenue
$1.40 million
Beat/Miss
Missed by -$499.00 thousand
YoY Revenue Growth
N/A

Arcadia Biosciences Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Arcadia Biosciences' Q1 2026 earnings is estimated for Thursday, May 7, 2026, based on past reporting schedules

Arcadia Biosciences Earnings Headlines

Elon Musk’s $1 Quadrillion AI IPO
$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.tc pixel
See More Arcadia Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email.

About Arcadia Biosciences

Arcadia Biosciences (NASDAQ:RKDA), founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients. The Crop Traits division develops seed traits such as drought tolerance, salt tolerance, and enhanced oil or fiber profiles, which are licensed to major seed companies for integration into commercial seed offerings. The Food Ingredients division leverages specialty crops to produce plant-based ingredients—including high-fiber wheat, functional starches, and plant proteins—targeted at food and beverage manufacturers seeking clean-label, nutritionally improved solutions.

To advance its pipeline and broaden its geographic footprint, Arcadia collaborates with global agricultural partners, research institutions, and development agencies. The company conducts field trials and pilot programs across North America, Australia, and Latin America, adapting its trait technologies to diverse agronomic conditions. With a commitment to environmental stewardship, Arcadia aims to reduce inputs such as water and synthetic fertilizers, thereby supporting sustainable agricultural practices. Through strategic alliances and a diversified portfolio, Arcadia Biosciences works to address global food security challenges and meet the growing consumer demand for healthier, more sustainable foods.

View Arcadia Biosciences Profile